EpilepsyGTX

Canterbury, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of gene therapies designed for neurological disorder treatment. EpilepsyGTX is based in Canterbury, United Kingdom and was founded in 2021. Its last reported valuation was $47.2 million in Dec 2025. It has raised $47.5 million.

Last reported valuation

$47.2M

Oct 2026

Priced at

—

Total raised

$47.5M

Last round

—

How much has EpilepsyGTX raised?

$47.5Macross 0 recorded rounds

Free account

More of EpilepsyGTX with a free account

·Watch EpilepsyGTX: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

EpilepsyGTX investors

10 investors are on record for EpilepsyGTX, including British Business Bank, UK Research and Innovation, AlbionVC and Zcube.

For fundraisers

Raising for a company like EpilepsyGTX?

10 investors have backed EpilepsyGTX.

See all 10 investors →

Frequently asked about EpilepsyGTX

How much has EpilepsyGTX raised?: EpilepsyGTX has raised $47.5M in total across 0 recorded funding rounds.